NCT02578043View on ClinicalTrials.gov

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris

PHASE1CompletedINTERVENTIONAL

Enrollment

844

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions

Acne Vulgaris

Interventions

DRUG

Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75%

Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% (Taro Pharmaceuticals Inc.)

DRUG

Onexton™ Gel

Onexton™ Gel (Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75%) (Valeant Pharmaceuticals LLC)

DRUG

Placebo

Placebo (vehicle of the test product) (Taro Pharmaceuticals Inc.)

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02578043 - A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter